Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer

References

• Hamra GB, Richardson DB, Dement J, et al. Lung cancer risk associated with regulated and unregulated chrysotile asbestos fibers. Epidemiology 2017;28:275–280.
   PubMed Web of Science ®Google Scholar
• Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32:605–644.
   PubMed Web of Science ®Google Scholar
• Melkamu T, Qian X, Upadhyaya P, et al. Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer. Vet Pathol. 2013;50:895–902.
   PubMed Web of Science ®Google Scholar
• Pan YW, Zhou ZG, Wang M, et al. Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis. Genet Mol Res. 2016;15:gmr15048949.
   Google Scholar
• Bichsel CA, Wang L, Froment L, et al. Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model. Sci Rep. 2017;7:10636.
   PubMed Web of Science ®Google Scholar
• Yin Y, Yao S, Hu Y, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL-6. Clin. Cancer Res. 2017;23:7375–7387.
   PubMed Web of Science ®Google Scholar
• Zhou C. Blood-based tumor markers in lung cancer. Zhongguo fei ai za. 2015;18:770–780.
   PubMedGoogle Scholar
• Street ME, Miraki MF, Sanderson IR, et al. Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells. J Endocrinol. 2003;179:405–415.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Sotiropoulos G, Karmaniolas K, et al. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem. 2013;46:584–590.
   PubMed Web of Science ®Google Scholar
• Rasoulinejad S, Gargari SL. Aptamer-nanobody based ELASA for specific detection of Acinetobacter baumannii isolates. J Biotechnol. 2016;231:46–54.
   PubMed Web of Science ®Google Scholar
• Rouf R, MacFarlane EG, Takimoto E, et al. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. JCI Insight. 2017;2.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang H, Hu R, et al. The expression and significance of neuronal iconic proteins in podocytes. PLoS One. 2014;9:e93999.
   PubMed Web of Science ®Google Scholar
• Liu G, Zhao L, Wang T, et al. Optimal therapeutic dose and time window of picroside II in cerebral ischemic injury. Neural Regen Res. 2014;9:1437–1445.
   PubMed Web of Science ®Google Scholar
• Kumar S, Kumar S, Tiwari S, et al. Biofunctionalized nanostructured zirconia for biomedical application: a smart approach for oral cancer detection. Adv Sci. 2015;2:1500048.
   Web of Science ®Google Scholar
• Kurien BT, Scofield RH. Western blotting: an introduction. Methods Mol Biol. 2015;1312:17–30.
   PubMedGoogle Scholar
• Speirs V, Kerin MJ, Walton DS, et al. Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells. Br J Cancer. 2000;82:1312–1316.
   PubMed Web of Science ®Google Scholar
• You S, Li R, Park D, et al. Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. Mol Cancer Ther. 2014;13:606–616.
   PubMed Web of Science ®Google Scholar
• Ray P, Ghosh SK, Zhang DH, et al. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Letters. 1997;409:79–85.
   PubMed Web of Science ®Google Scholar
• Bhat-Nakshatri P, Newton TR, Goulet R, Jr, et al. NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha. Proc Natl Acad Sci USA. 1998;95:6971–6976.
   PubMed Web of Science ®Google Scholar
• Wang LH, Yang XY, Mihalic K, et al. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PLAS3. J Biol Chem. 2001;276:31839–31844.
   PubMed Web of Science ®Google Scholar
• Shang GS, Liu L, Qin YW. IL-6 and TNF-alpha promote metastasis of lung cancer by inducing epithelial-mesenchymal transition. Oncol Letters. 2017;13:4657–4660.
   PubMed Web of Science ®Google Scholar
• Chang KT, Tsai CM, Chiou YC, et al. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol. 2005;289:L446–L453.
   PubMed Web of Science ®Google Scholar
• Fearon KCH, Barber MD, Moses AG, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006;24:3401–3407.
   PubMed Web of Science ®Google Scholar
• Liu LJ, Teng JL, Zhang LJ, et al. The combination of the tumor markers suggests the histological diagnosis of lung cancer. BioMed Res Int. 2017;2017:2013989.
   Google Scholar
• Gao WL, Wang WT, Yao SH, et al. Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays. Anal Chim Acta. 2017;958:77–84.
   PubMed Web of Science ®Google Scholar
• Wang HM, Zhang XH, Liu XK, et al. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer. J Can Res Ther. 2016;12:355–358.
   PubMed Web of Science ®Google Scholar
• Hanada S, Nishiyama N, Mizuguchi S, et al. Clinicopathological significance of combined analysis of cytokeratin19 expression and preoperative serum CYFRA21-1 levels in human lung squamous cell carcinoma. Osaka City Med J. 2013;59:35–44.
   PubMedGoogle Scholar
• Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer. 2001;32:61–69.
   PubMed Web of Science ®Google Scholar
• Yu DF, Du KQ, Liu TF, et al. Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC patients. Int J Mol Sci. 2013;14:11145–11156.
   PubMed Web of Science ®Google Scholar
• Danskyullmann C, Salgaller M, Adams S, et al. Synergistic effects of Il-6 and Ifn-Gamma on carcinoembryonic antigen (Cea) and Hla expression by human colorectal-carcinoma cells – role for endogenous Ifn-beta. Cytokine. 1995;7:118–129.
   PubMed Web of Science ®Google Scholar
• Lukaszewicz-Zajac M, Mroczko B, Gryko M, et al. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med. 2011;11:89–96.
   PubMed Web of Science ®Google Scholar
• Mroczko B, Groblewska M, Gryko M, et al. Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J Clin Lab Anal. 2010;24:256–261.
   PubMed Web of Science ®Google Scholar
• Wojcik E, Jakubowicz J, Skotnicki P, et al. IL-6 and VEGF in small cell lung cancer patients. Anticancer Res. 2010;30:1773–1778.
   PubMed Web of Science ®Google Scholar
• Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005;41:2502–2512.
   PubMed Web of Science ®Google Scholar
• Camacho-Leal P, Stanners CP. The human carcinoembryonic antigen (CEA) GPI anchor mediates anoikis inhibition by inactivation of the intrinsic death pathway. Oncogene. 2008;27:1545–1553.
   PubMed Web of Science ®Google Scholar